Mycosis fungoides and Sézary syndrome: Australian clinical practice statement

Friyana Bhabha(Peter MacCallum Cancer Centre), Christopher McCormack(Peter MacCallum Cancer Centre), Jillian Wells(The University of Sydney), Belinda A. Campbell(The University of Melbourne), Kate Newland(Royal Adelaide Hospital), Stephen Lade(Peter MacCallum Cancer Centre), Odette Buelens(Peter MacCallum Cancer Centre), David Joske(Sir Charles Gairdner Hospital), Jake Shortt(Monash Health), Sally Mapp(Princess Alexandra Hospital), Dejan Radeski(Sir Charles Gairdner Hospital), Mark Hertzberg(Prince of Wales Hospital), Amit Khot(Peter MacCallum Cancer Centre), Carrie van der Weyden(Peter MacCallum Cancer Centre), Christine Khoo(Peter MacCallum Cancer Centre), Eliza A. Hawkes(The University of Melbourne), H. Miles Prince(Peter MacCallum Cancer Centre)
Australasian Journal of Dermatology
December 26, 2020
Cited by 11Open Access
Full Text

Abstract

Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sézary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au).


Related Papers

No related papers found

Powered by citation graph analysis